Check out your Company Bowl for anonymous work chats.
Siloed systems and compliance obligations can hinder data sharing in healthcare. Our new blog post discusses how to overcome these challenges and foster a faster pipeline of discoveries and potential treatments by unlocking the value of your data.
Data Revolution: Meaningful Insights in Healthcare
Wastewater testing of samples from January 2025 detected measles in Houston before reported cases, demonstrating the power of wastewater monitoring for early outbreak detection. Researchers from Baylor College of Medicine and collaborators used a sequencing-based approach to identify the virus. Verily now offers sensitive and reliable wastewater monitoring for the measles virus, providing timely insights into community health.
Wastewater surveillance detects measles in Houston before cases are reported
Learn how Verily can unlock the value of biomedical data by breaking down data silos in a live webinar with Verily experts David Glazer and Shimon Rura on June 3 at 9:30 AM PT.
Unlock the value of your biomedical data
Clinical trials are notoriously inefficient, expensive, and dependent on research sites that are overburdened with cumbersome processes and technology. Watch how Verily and the American Oncology Network are supporting research aimed at bringing new treatments to market faster, helping to preserve our most precious resource — time.
A New View on Research
We congratulate Scott Burke, Verily Chief Technology Officer, for being named to The Healthcare Technology Report list of Top 25 Healthcare AI Executives of 2025! Scott leads Verily’s Technology org across software, hardware, AI and data science, IT, and security. He and fellow leaders are recognized for applying artificial intelligence to healthcare, with the ultimate goal of improving patient outcomes.
https://veri.ly/4jcsJNH
The Verily team was excited to participate in the Regeneron Digital Biomarker Summit this week! Sooyoon Shin, Senior Manager, Digital Biomarkers, gave a fantastic talk on our approach to measuring Parkinson’s disease progression in clinical trials using active and passive digital endpoints with Numetric Digital Measures.
The Verily team was excited to participate in the Regeneron Digital Biomarker Summit this week! Sooyoon Shin, Senior Manager, Digital Biomarkers, gave a fantastic talk on our approach to measuring Parkinson’s disease progression in clinical trials using active and passive digital endpoints with Numetric Digital Measures.
For data scientists working in healthcare, the ability to govern, analyze and collaborate on the right data remains a challenge, and can slow down the pace of biomedical research. Platforms like Verily Workbench provide the infrastructure and collaborative tools to unlock the value of multimodal health data at scale, enabling biomedical research.
Breaking down barriers to advance biomedical research
Together with The Michael J. Fox Foundation for Parkinson's Research (MJFF), we’re expanding the impact of the Personalized Parkinson’s Project (PPP), a two-year study of 520 people with Parkinson’s led by Verily and Radboud University Medical Center. Recently, we received a $14.7M grant to generate a comprehensive molecular dataset from the PPP. The data will be made available to researchers globally using Verily’s Workbench platform, aiming to improve understanding and treatment of Parkinson’s disease.
MJFF Issues Grant to Expand, Leverage Important Parkinson's Dataset
Measles cases are rising in the US, posing a significant public health risk. Early detection is critical to help mitigate the spread. With the development of a new assay, Verily Sightline now offers wastewater monitoring for measles, enabling early warning and ongoing monitoring to inform public health strategies and communications.
Verily Sightline Wastewater Monitoring
Employers are facing challenges with GLP-1 coverage costs. In our recent webinar moderated by Lydia Ramsey Pflanzer of Endpoints News, David Burdick, Sarah Thompson, and Heidi Guetzkow discussed how employers are navigating coverage decisions and incorporating weight management programs like Verily Lightpath*. Hear more about this trend and how Verily is addressing GLP-1 management. * To be available in 2026
Unlocking GLP-1 potential: Better outcomes, bigger savings